Vitamin D Supplementation in Selected Autoimmune Diseases
DOI:
https://doi.org/10.12775/QS.2024.27.55650Keywords
vitamin D, rheumatoid arthritis, ; Hashimoto’s disease, ulcerative colitis, psoriasis, diabetes mellitus type 1, multiple sclerosisAbstract
Introduction and Objective. In recent years, awareness of the problem of vitamin D deficiency in the human body has been steadily increasing. There is a growing emphasis on investigating the effects of vitamin D supplementation both in the prevention of autoimmune diseases and in the course of existing diseases. The aim of this study is to highlight and discuss the role of vitamin D supplementation in selected autoimmune diseases.
Review methods. The publication is a narrative review. The PubMed electronic database was used to review the literature. To ensure the highest substantive value, the focus was mainly on studies from the last 8 years, with only 6 studies published before 2016, concerning autoimmune diseases.
Results. There are still lots of unknowns when it comes to physiology and the role that vitamin D plays in our body and deepening the knowledge of its functions would definitely help prevent many diseases concerning various systems such as musculoskeletal, immune and nervous systems. Wide range of studies have already proven that appropriate supplementation of vitamin D prevents complications and exacerbations of disorders like rheumatoid arthritis, Hashimoto’s thyroiditis, ulcerative colitis, type 1 diabetes and multiple sclerosis. Unfortunately there is no unambiguous evidence of noticeable improvement in the patients suffering from psoriasis after taking vitamin D. There is a huge need for developing guidelines which would establish specific supplementation protocols considering various factors since it is inexplicably difficult to obtain an optimal level of vitamin D in our body.
Summary. The increasing prevalence of autoimmune diseases in the population, their coexistence with vitamin D deficiency, and the scientifically proven impact of this vitamin on the body imply the need for an in-depth analysis of the relationship between its supplementation and the prevention and modification of the course of autoimmune diseases.
References
Moridi I, Chen A, Tal O, et al. The Association between Vitamin D and Anti-Müllerian Hormone: A Systematic Review and Meta-Analysis. Nutrients. 2020 May 28;12(6):1567. doi: 10.3390/nu12061567. PMID: 32481491; PMCID: PMC7352921.
Stojanović E, Radovanović D, Hew-Butler T, et al. Vitamin D in Basketball Players: Current Evidence and Future Directions. Sports Health. 2022 May-Jun;14(3):377-388. doi: 10.1177/19417381211019343. Epub 2021 Jun 4. PMID: 34085865; PMCID: PMC9112709.
Bleakley AS, Licciardi PV, Binks MJ. Vitamin D Modulation of the Innate Immune Response to Paediatric Respiratory Pathogens Associated with Acute Lower Respiratory Infections. Nutrients. 2021 Jan 19;13(1):276. doi: 10.3390/nu13010276. PMID: 33478006; PMCID: PMC7835957.
Cabral JA, Souza GP, Nascimento JA, et al. IMPACT OF VITAMIN D AND CALCIUM DEFICIENCY IN THE BONES OF PATIENTS UNDERGOING BARIATRIC SURGERY: A SYSTEMATIC REVIEW. Arq Bras Cir Dig. 2016;29Suppl 1(Suppl 1):120-123. doi: 10.1590/0102-6720201600S10029. PMID: 27683792; PMCID: PMC5064268.
Kalaitzopoulos DR, Samartzis N, Daniilidis A, et al. Effects of vitamin D supplementation in endometriosis: a systematic review. Reprod Biol Endocrinol. 2022 Dec 28;20(1):176. doi: 10.1186/s12958-022-01051-9. PMID: 36578019; PMCID: PMC9795583.
Megaw L, Clemens T, Dibben C, et al. Pregnancy outcome and ultraviolet radiation; A systematic review. Environ Res. 2017 May;155:335-343. doi: 10.1016/j.envres.2017.02.026. Epub 2017 Mar 10. PMID: 28264782.
Bjelakovic M, Nikolova D, Bjelakovic G, et al. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database Syst Rev. 2021 Aug 25;8(8):CD011564. doi: 10.1002/14651858.CD011564.pub3. PMID: 34431511; PMCID: PMC8407054.
Zamoner SMS, Takase HM, Riyuzo MC, et al. Safety of cinacalcet in children and adolescents with chronic kidney disease-mineral bone disorder: systematic review and proportional meta-analysis of case series. Int Urol Nephrol. 2024 May;56(5):1669-1676. doi: 10.1007/s11255-023-03844-2. Epub 2023 Nov 15. PMID: 37964112; PMCID: PMC11001724.
Ferguson JH, Chang AB. Vitamin D supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews 2014, Issue 5. Art. No.: CD007298. DOI: 10.1002/14651858.CD007298.pub4.
Tao X, Yang W, Zhang Q, et al. Effects of intermittent overload doses of oral vitamin D3 on serum 25(OH)D concentrations and the incidence rates of fractures, falls, and mortality in elderly individuals: A systematic review and meta-analysis. Biomol Biomed. 2024 Sep 6;24(5):1068-1076. doi: 10.17305/bb.2024.10449. PMID: 38615341; PMCID: PMC11379009.
Rios-Leyvraz M, Thacher TD, Dabas A, et al. Serum 25-hydroxyvitamin D threshold and risk of rickets in young children: a systematic review and individual participant data meta-analysis to inform the development of dietary requirements for vitamin D. Eur J Nutr. 2024 Apr;63(3):673-695. doi: 10.1007/s00394-023-03299-2. Epub 2024 Jan 27. PMID: 38280944; PMCID: PMC10948504.
Wimalawansa SJ. Infections and Autoimmunity-The Immune System and Vitamin D: A Systematic Review. Nutrients. 2023 Sep 2;15(17):3842. doi: 10.3390/nu15173842. PMID: 37686873; PMCID: PMC10490553.
Cui A, Zhang T, Xiao P, et al. Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants. Front Nutr. 2023 Mar 17;10:1070808. doi: 10.3389/fnut.2023.1070808. PMID: 37006940; PMCID: PMC10064807.
Pludowski P. Supplementing Vitamin D in Different Patient Groups to Reduce Deficiency. Nutrients. 2023 Aug 25;15(17):3725. doi: 10.3390/nu15173725. PMID: 37686757; PMCID: PMC10489803.
Athanassiou L, Kostoglou-Athanassiou I, Koutsilieris M, et al. Vitamin D and Autoimmune Rheumatic Diseases. Biomolecules. 2023 Apr 21;13(4):709. doi: 10.3390/biom13040709. PMID: 37189455; PMCID: PMC10135889.
Harrold LR, Bryson J, Lehman T, et al. Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients with RA. Rheumatol Ther. 2021 Jun;8(2):937-953. doi: 10.1007/s40744-021-00310-2. Epub 2021 May 28. PMID: 34047953; PMCID: PMC8217398.
Lönnblom E, Leu Agelii M, Sareila O, et al. Autoantibodies to Disease-Related Proteins in Joints as Novel Biomarkers for the Diagnosis of Rheumatoid Arthritis. Arthritis Rheumatol. 2023 Jul;75(7):1110-1119. doi: 10.1002/art.42463. Epub 2023 Apr 27. PMID: 36718635.
Lourinho I, Sousa T, Jardim R, et al. Effects of low-level laser therapy in adults with rheumatoid arthritis: A systematic review and meta-analysis of controlled trials. PLoS One. 2023 Sep 8;18(9):e0291345. doi: 10.1371/journal.pone.0291345. PMID: 37683021; PMCID: PMC10490856.
Al-Saoodi H, Kolahdooz F, Andersen JR, et al. Effect of vitamin D on inflammatory and clinical outcomes in patients with rheumatoid arthritis: a systematic review and dose-response meta-analysis of randomized controlled trials. Nutr Rev. 2024 Apr 12;82(5):600-611. doi: 10.1093/nutrit/nuad083. PMID: 37437898.
Harrison SR, Li D, Jeffery LE, et al. Vitamin D, Autoimmune Disease and Rheumatoid Arthritis. Calcif Tissue Int. 2020 Jan;106(1):58-75. doi: 10.1007/s00223-019-00577-2. Epub 2019 Jul 8. PMID: 31286174; PMCID: PMC6960236.
Rangaswamaiah S, Gangathimmaiah V, Nordenstrom A, et al. Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2020 Jul 31;11:493. doi: 10.3389/fendo.2020.00493. PMID: 32903805; PMCID: PMC7438951.
Chahardoli R, Saboor-Yaraghi AA, Amouzegar A, et al. Can Supplementation with Vitamin D Modify Thyroid Autoantibodies (Anti-TPO Ab, Anti-Tg Ab) and Thyroid Profile (T3, T4, TSH) in Hashimoto's Thyroiditis? A Double Blind, Randomized Clinical Trial. Horm Metab Res. 2019 May;51(5):296-301. doi: 10.1055/a-0856-1044. Epub 2019 May 9. PMID: 31071734.
Alghamdi M, Alyousfi D, Mukhtar MS, et al. Association between vedolizumab and risk of clostridium difficile infection in patients with ulcerative colitis: A systematic review and meta-analysis. Saudi J Gastroenterol. 2024 Jun 7. doi: 10.4103/sjg.sjg_118_24. Epub ahead of print. PMID: 38847060.
Azadbakht S, Seighali M, Azadbakht S, et al. Effectiveness of adalimumab in severe ulcerative colitis: A systematic review and a meta-analysis. Health Sci Rep. 2024 Jul 18;7(7):e2210. doi: 10.1002/hsr2.2210. PMID: 39035679; PMCID: PMC11258201.
Osigwe PC, Agomoh CE, Osigwe IS, et al. The Association Between Psoriasis and Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis of Observational Studies. Cureus. 2024 Jun 28;16(6):e63379. doi: 10.7759/cureus.63379. PMID: 38947134; PMCID: PMC11213549.
Sbidian E, Chaimani A, Guelimi R, et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev. 2023 Jul 12;7(7):CD011535. doi: 10.1002/14651858.CD011535.pub6. PMID: 37436070; PMCID: PMC10337265.
Arneth B. Current Knowledge about Nonclassical Monocytes in Patients with Multiple Sclerosis, a Systematic Review. Int J Mol Sci. 2024 Jul 5;25(13):7372. doi: 10.3390/ijms25137372. PMID: 39000478; PMCID: PMC11242477.
Ghazanfar S, Farooq M, Qazi SU, et al. The use of modafinil for the treatment of fatigue in multiple sclerosis: A systematic review and meta-analysis of controlled clinical trials. Brain Behav. 2024 Jul;14(7):e3623. doi: 10.1002/brb3.3623. PMID: 38988104; PMCID: PMC11237168.
Kawasaki E. Anti-Islet Autoantibodies in Type 1 Diabetes. Int J Mol Sci. 2023 Jun 11;24(12):10012. doi: 10.3390/ijms241210012. PMID: 37373160; PMCID: PMC10298549.
Calderon Martinez E, Castillo JL, Zachariah Saji S, et al. Insulin Pump Therapy vs Multiple Daily Insulin Injections for Glycemic Control in Children With Type 1 Diabetes: A Systematic Review and Meta-Analysis. Cureus. 2024 Jan 10;16(1):e52054. doi: 10.7759/cureus.52054. PMID: 38344584; PMCID: PMC10855014.
Roy SS, Keshri USP, Alam MS, et al. Effect of Immunotherapy on C-peptide Levels in Patients With Type I Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials. Cureus. 2024 Apr 25;16(4):e58981. doi: 10.7759/cureus.58981. PMID: 38800168; PMCID: PMC11127502.
Triebl Z, Bencze B, Bányai D, et al. Poor glycemic control impairs oral health in children with type 1 diabetes mellitus - a systematic review and meta-analysis. BMC Oral Health. 2024 Jun 28;24(1):748. doi: 10.1186/s12903-024-04516-y. PMID: 38943074; PMCID: PMC11212250.
Clasen JL, Cole R, Aune D, et al. Vitamin D status and risk of rheumatoid arthritis: systematic review and meta-analysis. BMC Rheumatol. 2023 Mar 15;7(1):3. doi: 10.1186/s41927-023-00325-y. PMID: 36918989; PMCID: PMC10015722.
Mouterde G, Gamon E, Rincheval N, et al. Association Between Vitamin D Deficiency and Disease Activity, Disability, and Radiographic Progression in Early Rheumatoid Arthritis: The ESPOIR Cohort. J Rheumatol. 2020 Nov 1;47(11):1624-1628. doi: 10.3899/jrheum.190795. Epub 2019 Dec 15. PMID: 31839594.
Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007 Aug 1;179(3):1634-47. doi: 10.4049/jimmunol.179.3.1634. PMID: 17641030.
Cippitelli M, Fionda C, Di Bona D, et al. Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes. J Immunol. 2002 Feb 1;168(3):1154-66. doi: 10.4049/jimmunol.168.3.1154. PMID: 11801650.
Zhang J, Chen Y, Li H, et al. Effects of vitamin D on thyroid autoimmunity markers in Hashimoto's thyroiditis: systematic review and meta-analysis. J Int Med Res. 2021 Dec;49(12):3000605211060675. doi: 10.1177/03000605211060675. PMID: 34871506; PMCID: PMC8711703.
Liu C, Liu X, Shi H, et al. The correlation between serum 25-hydroxyvitamin D level and ulcerative colitis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2023 Dec 1;35(12):1375-1381. doi: 10.1097/MEG.0000000000002670. Epub 2023 Oct 17. PMID: 37851357.
Stio M, Retico L, Annese V, et al. Vitamin D regulates the tight-junction protein expression in active ulcerative colitis. Scand J Gastroenterol. 2016 Oct;51(10):1193-9. doi: 10.1080/00365521.2016.1185463. Epub 2016 May 20. PMID: 27207502.
Sharifi A, Vahedi H, Honarvar MR, et al. Vitamin D decreases CD40L gene expression in ulcerative colitis patients: A randomized, double-blinded, placebo-controlled trial. Turk J Gastroenterol. 2020 Feb;31(2):99-104. doi: 10.5152/tjg.2020.181028. PMID: 32141817; PMCID: PMC7062129.
Gubatan J, Mitsuhashi S, Longhi MS, et al. Higher serum vitamin D levels are associated with protective serum cytokine profiles in patients with ulcerative colitis. Cytokine. 2018 Mar;103:38-45. doi: 10.1016/j.cyto.2017.12.023. Epub 2018 Jan 8. PMID: 29324259; PMCID: PMC5808893.
Emami MR, Sharifi A, Yaseri M, et al. Vitamin D suppresses proangiogenic factors in patients with ulcerative colitis: A randomized double blind placebo controlled clinical trial. Complement Ther Clin Pract. 2020 May;39:101086. doi: 10.1016/j.ctcp.2020.101086. Epub 2020 Jan 7. PMID: 31957666.
Mathur J, Naing S, Mills P, et al. A randomized clinical trial of vitamin D3 (cholecalciferol) in ulcerative colitis patients with hypovitaminosis D3. PeerJ. 2017 Aug 3;5:e3654. doi: 10.7717/peerj.3654. PMID: 28791200; PMCID: PMC5545112.
Javad Hosseinzadeh-Attar M, Sharifi A, Nedjat S, et al. The Effect of Vitamin D on Serum Asymmetric Dimethylarginine in Patients with Mild to Moderate Ulcerative Colitis. Int J Vitam Nutr Res. 2020 Jan;90(1-2):17-22. doi: 10.1024/0300-9831/a000303. Epub 2019 Apr 15. PMID: 30982443.
Guan Y, Hao Y, Guan Y, et al. Effects of vitamin D supplementation on blood markers in ulcerative colitis patients: a systematic review and meta-analysis. Eur J Nutr. 2022 Feb;61(1):23-35. doi: 10.1007/s00394-021-02603-2. Epub 2021 Jun 1. PMID: 34075433.
Guo X, Liu C, Huang Y. Efficacy and Safety of Vitamin D Adjuvant Therapy for Ulcerative Colitis: A Meta-Analysis. Comput Math Methods Med. 2022 Jul 20;2022:6836942. doi: 10.1155/2022/6836942. PMID: 35912148; PMCID: PMC9328974.
Formisano E, Proietti E, Borgarelli C, et al. Psoriasis and Vitamin D: A Systematic Review and Meta-Analysis. Nutrients. 2023 Jul 30;15(15):3387. doi: 10.3390/nu15153387. PMID: 37571324; PMCID: PMC10421389.
Barrea L, Savanelli MC, Di Somma C, et al. Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist. Rev Endocr Metab Disord. 2017 Jun;18(2):195-205. doi: 10.1007/s11154-017-9411-6. PMID: 28176237; PMCID: PMC5486909.
DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018 Jun 16;391(10138):2449-2462. doi: 10.1016/S0140-6736(18)31320-5. PMID: 29916386; PMCID: PMC6661119.
He LP, Song YX, Zhu T, et al. Progress in the Relationship between Vitamin D Deficiency and the Incidence of Type 1 Diabetes Mellitus in Children. J Diabetes Res. 2022 Sep 2;2022:5953562. doi: 10.1155/2022/5953562. PMID: 36090587; PMCID: PMC9463035.
Singh PK, van den Berg PR, Long MD, et al. Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes. BMC Genomics. 2017 Feb 6;18(1):132. doi: 10.1186/s12864-017-3481-4. PMID: 28166722; PMCID: PMC5294817.
Gabbay MA, Sato MN, Finazzo C, et al. Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual β-cell function in new-onset type 1 diabetes mellitus. Arch Pediatr Adolesc Med. 2012 Jul 1;166(7):601-7. doi: 10.1001/archpediatrics.2012.164. PMID: 22751874.
Yu J, Sharma P, Girgis CM, et al. Vitamin D and Beta Cells in Type 1 Diabetes: A Systematic Review. Int J Mol Sci. 2022 Nov 20;23(22):14434. doi: 10.3390/ijms232214434. PMID: 36430915; PMCID: PMC9696701.
Contreras-Bolívar V, García-Fontana B, García-Fontana C, et al. Mechanisms Involved in the Relationship between Vitamin D and Insulin Resistance: Impact on Clinical Practice. Nutrients. 2021 Oct 1;13(10):3491. doi: 10.3390/nu13103491. PMID: 34684492; PMCID: PMC8539968.
Aderinto N, Olatunji G, Kokori E, et al. High-dose vitamin D supplementation in multiple sclerosis: a systematic review of clinical effects and future directions. Discov Med 1. 2024 Dec. doi: 10.1007/s44337-024-00023-9.
Sintzel MB, Rametta M, Reder AT. Vitamin D and Multiple Sclerosis: A Comprehensive Review. Neurol Ther. 2018 Jun;7(1):59-85. doi: 10.1007/s40120-017-0086-4. Epub 2017 Dec 14. PMID: 29243029; PMCID: PMC5990512.
Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 Dec 20;296(23):2832-8. doi: 10.1001/jama.296.23.2832. PMID: 17179460.
Runia TF, Hop WC, de Rijke YB, et al. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology. 2012 Jul 17;79(3):261-6. doi: 10.1212/WNL.0b013e31825fdec7. Epub 2012 Jun 13. PMID: 22700811.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Monika Kamińska, Aleksandra Kozioł, Magdalena Agata Miernik-Skrzypczak, Natalia Dąbrowska, Adrian Uchto, Patrycja Karnas-Bogacka, Marta Katarzyna Malicka, Maria Jasiewicz, Katarzyna Moczyróg
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 176
Number of citations: 0